Financhill
Sell
48

BBIO Quote, Financials, Valuation and Earnings

Last price:
$35.19
Seasonality move :
1.07%
Day range:
$36.03 - $37.06
52-week range:
$21.62 - $39.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
30.52x
P/B ratio:
--
Volume:
1.5M
Avg. volume:
3.4M
1-year change:
17.95%
Market cap:
$6.9B
Revenue:
$221.9M
EPS (TTM):
-$2.85

Earnings Data

Next earnings date for BBIO
May 02
2025
Most recent earnings per share
-$1.40
Missed by $0.31
(Feb 20/2025)
Consensus Estimate
-$1.09
(Feb 20/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BBIO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/02/2025 Q1 $57.1M -- -- -$0.86 --
02/20/2025 Q4 $4M $5.9M -$1.40 -$1.09 -$0.31
11/12/2024 Q3 $3.4M $2.7M -$0.86 -$0.86 --
08/01/2024 Q2 $4.5M $2.2M -$0.39 -$0.94 $0.55
05/02/2024 Q1 $83.8M $211.1M -$0.20 -$0.54 $0.34
02/22/2024 Q4 $3.8M $1.7M -$0.96 -$0.80 -$0.16
11/02/2023 Q3 -- -- -$1.08 -$0.89 -$0.19
08/03/2023 Q2 -- -- -$0.98 -$0.88 -$0.11
05/04/2023 Q1 -- -- -$0.92 -$0.83 -$0.09
02/23/2023 Q4 -- -- -$0.92 -$0.94 $0.02
11/03/2022 Q3 -- -- -$0.93 -$1.01 $0.08
08/04/2022 Q2 -- -- -$0.07 -$0.86 $0.79
05/05/2022 Q1 -- -- -$1.35 -$1.10 -$0.25
02/24/2022 Q4 -- -- -$1.01 -$0.91 -$0.10
11/04/2021 Q3 -- -- -$1.06 -$0.91 -$0.15
08/05/2021 Q2 -- -- -$0.66 -$0.89 $0.23
05/06/2021 Q1 -- -- -$1.18 -$0.75 -$0.43
02/25/2021 Q4 -- -- -$1.01 -$0.86 -$0.15
11/05/2020 Q3 -- -- -$0.98 -$0.89 -$0.09
08/11/2020 Q2 -- -- -$1.03 -$0.73 -$0.30
05/13/2020 Q1 -- -- -$0.78 -$0.70 -$0.08
03/02/2020 Q4 -- -- -$0.62 -$0.63 $0.01
11/07/2019 Q3 -- -- -$0.51 -$0.54 $0.03
08/14/2019 Q2 -- -- -$0.71 -$0.40 -$0.31
03/31/2019 Q1 -- -- -$0.51 -- --
12/31/2018 Q4 -- -- -$0.42 -- --
09/30/2018 Q3 -- -- -$0.34 -- --
06/30/2018 Q2 -- -- -$0.33 -- --
03/31/2018 Q1 -- -- -$0.40 -- --

BridgeBio Pharma Earnings Questions

  • How Much did BridgeBio Pharma Generate in Revenue Last Quarter?

    BridgeBio Pharma reported $5.9M worth of top line sales in its most recent quarter.

  • Did BridgeBio Pharma Beat Earnings Last Quarter?

    BridgeBio Pharma announced earnings per share of -$1.40 which represents a miss of analyst forecast a -$1.09 per share.

  • Is BridgeBio Pharma Profitable?

    BridgeBio Pharma reported $3.8M that represents $0.02 per share over the last quarter.

  • What is the Analyst Consensus for BridgeBio Pharma EPS Next Year?

    BridgeBio Pharma's earnings are forecast to decrease from -$2.88 per share to -$2.39 per share next year representing a decrease of -29.8%.

  • When is BridgeBio Pharma's Earnings Date?

    BridgeBio Pharma's next earnings date is May 2, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Finally Time to Buy Medical Properties Trust?
Is it Finally Time to Buy Medical Properties Trust?

Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…

Why Did Signet Jewelers Stock Go Up So Much?
Why Did Signet Jewelers Stock Go Up So Much?

Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…

Why Did HealthEquity Stock Fall So Much?
Why Did HealthEquity Stock Fall So Much?

HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Sell
44
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Buy
69
CNXC alert for Mar 28

Concentrix [CNXC] is down 15.28% over the past day.

Buy
74
SLNO alert for Mar 28

Soleno Therapeutics [SLNO] is up 8.24% over the past day.

Buy
51
CAR alert for Mar 28

Avis Budget Group [CAR] is down 3.25% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock